| Names | |
|---|---|
|  IUPAC name  Methyl (7R,16E)-17-methoxy-2-oxo-16,17-didehydro-20α-corynoxan-16-carboxylate  | |
|  Systematic IUPAC name  Methyl (2E)-2-[(1′R,6′R,7′S,8a′S)-6′-ethyl-2-oxo-1,2,2′,3′,6′,7′,8′,8a′-octahydro-5′H-spiro[indole-3,1′-indolizin]-7′-yl]-3-methoxyprop-2-enoate  | |
Other names 
  | |
| Identifiers | |
3D model (JSmol)  | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.208.612 | 
| KEGG | |
 PubChem CID  | |
| UNII | |
 CompTox Dashboard (EPA)  | |
  | |
  | |
| Properties | |
| C22H28N2O4 | |
| Molar mass | 384.476 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  | |
Rhynchophylline is an alkaloid found in certain Uncaria species (Rubiaceae), notably Uncaria rhynchophylla [1] and Uncaria tomentosa . [2] It also occurs in the leaves of Mitragyna speciosa (kratom) and Mitragyna tubulosa, [3] a tree native to Thailand. Chemically, it is related to the alkaloid mitragynine.
Rhynchophylline is a non-competitive NMDA antagonist (IC50 = 43.2 μM) and a calcium channel blocker. [4] [5]
Uncaria species have had a variety of uses in traditional herbal medicine, such as for lightheadedness, convulsions, numbness, and hypertension. [6] These uses have been associated with the presence of rhynchophylline and have encouraged its investigation as a drug candidate for several cardiovascular and central nervous system diseases; however, few clinically relevant studies have been conducted. [6]